{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:52:35Z","timestamp":1788976355590,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","award":["R01EY032456"],"award-info":[{"award-number":["R01EY032456"]}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}]},{"name":"The Frederic C. Hamilton Macular Degeneration Center Sue Anschutz-Rodgers Eye Center Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31051-9","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:53:59Z","timestamp":1765043639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between systemic complement levels and choroidal thickness in advanced non-neovascular age-related macular degeneration"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-1509","authenticated-orcid":false,"given":"Talisa","family":"E de Carlo Forest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Itzam","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Gnanaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Poppelaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T.","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Frazer-Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Michael","family":"Holers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Mandava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"issue":"4","key":"31051_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris, F. L. et al. Clinical classification of age-related macular degeneration. Ophthalmology 120 (4), 844\u2013851 (2013).","journal-title":"Ophthalmology"},{"issue":"4","key":"31051_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda, S. R. et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology 125 (4), 537\u2013548 (2018).","journal-title":"Ophthalmology"},{"key":"31051_CR3","unstructured":"Guymer, R. H. et al. Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: Classification of atrophy meeting report 4. Ophthalmology 127(3), 394\u2013409 (202)."},{"issue":"2","key":"31051_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche, L. G. et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat. Genet. 48 (2), 134\u2013143 (2016).","journal-title":"Nat. Genet."},{"key":"31051_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fnmol.2017.00197","volume":"10","author":"N Schafer","year":"2017","unstructured":"Schafer, N., Grosche, A., Schmitt, S. I., Braunger, B. M. & Pauly, D. Complement components showed a time-dependent local expression pattern in constant and acute white light-induced photoreceptor damage. Front. Mol. Neurosci. 10, 197 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"31051_CR6","doi-asserted-by":"crossref","unstructured":"Wang, L. et al. Abundant lipid and protein components of Drusen. PLoS One 5(4), e10329 (2010).","DOI":"10.1371\/journal.pone.0010329"},{"issue":"5","key":"31051_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/tvst.11.5.22","volume":"11","author":"AI Marin","year":"2022","unstructured":"Marin, A. I. et al. Sex and age-related differences in complement factors among patients with intermediate age-related macular degeneration. Transl Vis. Sci. Technol. 11 (5), 22 (2022).","journal-title":"Transl Vis. Sci. Technol."},{"issue":"5","key":"31051_CR8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1177\/1120672119857896","volume":"30","author":"AM Lynch","year":"2020","unstructured":"Lynch, A. M. et al. Systemic activation of the complement system in patients with advanced age-related macular degeneration. Eur. J. Ophthalmol. 30 (5), 1061\u20131068 (2020).","journal-title":"Eur. J. Ophthalmol."},{"key":"31051_CR9","doi-asserted-by":"crossref","unstructured":"Lynch, A. M. et al. Complement factors and reticular Pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging. BMJ Open. Ophthalmol. 5(1), e000361 (2020).","DOI":"10.1136\/bmjophth-2019-000361"},{"issue":"3","key":"31051_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.61.3.18","volume":"61","author":"TJ Heesterbeek","year":"2020","unstructured":"Heesterbeek, T. J. et al. Complement activation levels are related to disease stage in AMD. Invest. Ophthalmol. Vis. Sci. 61 (3), 18 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"31051_CR11","doi-asserted-by":"crossref","unstructured":"Ristau, T. et al. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels. PLoS One 9(3), e93459 (2014).","DOI":"10.1371\/journal.pone.0093459"},{"issue":"7","key":"31051_CR12","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2017.12.023","volume":"125","author":"L Lores-Motta","year":"2018","unstructured":"Lores-Motta, L. et al. Genome-wide association study reveals variants in CFH and CFHR4 associated with systemic complement activation: implications in age-related macular degeneration. Ophthalmology 125 (7), 1064\u20131074 (2018).","journal-title":"Ophthalmology"},{"issue":"3","key":"31051_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/hmg\/ddab256","volume":"31","author":"S de Jong","year":"2022","unstructured":"de Jong, S. et al. Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene. Hum. Mol. Genet. 31 (3), 455\u2013470 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"31051_CR14","doi-asserted-by":"publisher","first-page":"26568","DOI":"10.1038\/srep26568","volume":"6","author":"CC Paun","year":"2016","unstructured":"Paun, C. C. et al. A novel complotype combination associates with age-related macular degeneration and high complement activation levels in vivo. Sci. Rep. 6, 26568 (2016).","journal-title":"Sci. Rep."},{"issue":"7","key":"31051_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3928\/23258160-20250217-01","volume":"56","author":"RA Goldberg","year":"2025","unstructured":"Goldberg, R. A. et al. Pegcetacoplan for geographic atrophy over 30 months: data from OAKS, DERBY, and the GALE long-term extension study. Ophthalmic Surg. Lasers Imaging Retina. 56 (7), 398\u2013406 (2025).","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"issue":"4","key":"31051_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","volume":"128","author":"GJ Jaffe","year":"2021","unstructured":"Jaffe, G. J. et al. C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: A randomized pivotal phase 2\/3 trial. Ophthalmology 128 (4), 576\u2013586 (2021).","journal-title":"Ophthalmology"},{"key":"31051_CR17","doi-asserted-by":"crossref","unstructured":"Halawa, O. A., Lin, J. B., Miller, J. W. & Vavvas, D. G. A review of completed and ongoing complement inhibitor trials for geographic atrophy secondary to age-related macular degeneration. J Clin. Med 10(12) (2021).","DOI":"10.3390\/jcm10122580"},{"key":"31051_CR18","unstructured":"Murphy, K. & Weaver, C. Janeway\u2019s immunobiology. 9th Ed. 1-904 (Garland Science\/Taylor & Francis Group, LLC, 2016)."},{"key":"31051_CR19","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3389\/fimmu.2020.01643","volume":"11","author":"RGM Lammerts","year":"2020","unstructured":"Lammerts, R. G. M. et al. Properdin pattern recognition on proximal tubular cells is heparan sulfate\/Syndecan-1 but not C3b dependent and can be blocked by tick protein Salp20. Front. Immunol. 11, 1643 (2020).","journal-title":"Front. Immunol."},{"issue":"6","key":"31051_CR20","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.kint.2018.06.030","volume":"94","author":"J O\u2019Flynn","year":"2018","unstructured":"O\u2019Flynn, J. et al. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease. Kidney Int. 94 (6), 1141\u20131150 (2018).","journal-title":"Kidney Int."},{"issue":"3","key":"31051_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2249.2006.03072.x","volume":"144","author":"M Harboe","year":"2006","unstructured":"Harboe, M. et al. Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions. Clin. Exp. Immunol. 144 (3), 512\u2013520 (2006).","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"31051_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2249.2004.02627.x","volume":"138","author":"M Harboe","year":"2004","unstructured":"Harboe, M., Ulvund, G., Vien, L., Fung, M. & Mollnes, T. E. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin. Exp. Immunol. 138 (3), 439\u2013446 (2004).","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"31051_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris, M. & Remuzzi, G. Overview of complement activation and regulation. Semin Nephrol. 33 (6), 479\u2013492 (2013).","journal-title":"Semin Nephrol."},{"issue":"5","key":"31051_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ajo.2008.12.008","volume":"147","author":"R Margolis","year":"2009","unstructured":"Margolis, R. & Spaide, R. F. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am. J. Ophthalmol. 147 (5), 811\u2013815 (2009).","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"31051_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.oret.2020.09.001","volume":"5","author":"M Sasaki","year":"2021","unstructured":"Sasaki, M. et al. Association of choroidal thickness with intermediate age-related macular degeneration in a Japanese population. Ophthalmol. Retina. 5 (6), 528\u2013535 (2021).","journal-title":"Ophthalmol. Retina"},{"issue":"5","key":"31051_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3928\/23258160-20150521-02","volume":"46","author":"MR Thorell","year":"2015","unstructured":"Thorell, M. R. et al. Association between subfoveal choroidal thickness, reticular pseudodrusen, and geographic atrophy in age-related macular degeneration. Ophthalmic Surg. Lasers Imaging Retina. 46 (5), 513\u2013521 (2015).","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"issue":"1\u20132","key":"31051_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000468949","volume":"238","author":"M Oeverhaus","year":"2017","unstructured":"Oeverhaus, M., Meyer Zu Westrup, V., Dietzel, M., Hense, H. W. & Pauleikhoff, D. Genetic polymorphisms and the phenotypic characterization of individuals with early age-related macular degeneration. Ophthalmologica 238 (1\u20132), 6\u201316 (2017).","journal-title":"Ophthalmologica"},{"issue":"11","key":"31051_CR28","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.ajpath.2014.07.017","volume":"184","author":"RF Mullins","year":"2014","unstructured":"Mullins, R. F. et al. The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning. Am. J. Pathol. 184 (11), 3142\u20133153 (2014).","journal-title":"Am. J. Pathol."},{"issue":"11","key":"31051_CR29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.oret.2023.07.005","volume":"7","author":"SE Smith","year":"2023","unstructured":"Smith, S. E. et al. Visual functioning and mortality of age-related macular degeneration patients in a Colorado cohort. Ophthalmol. Retina. 7 (11), 982\u2013989 (2023).","journal-title":"Ophthalmol. Retina"},{"issue":"4","key":"31051_CR30","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/jcm12041505","volume":"12","author":"N Mihara","year":"2023","unstructured":"Mihara, N. et al. Sex- and age-dependent wide-field choroidal thickness differences in healthy eyes. J. Clin. Med. 12 (4), 1505 (2023).","journal-title":"J. Clin. Med."},{"issue":"6","key":"31051_CR31","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/02713683.2018.1428995","volume":"43","author":"W Wang","year":"2018","unstructured":"Wang, W., He, M. & Zhong, X. Sex-Dependent choroidal thickness differences in healthy adults: A study based on original and synthesized data. Curr. Eye Res. 43 (6), 796\u2013803 (2018).","journal-title":"Curr. Eye Res."},{"key":"31051_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-030-27378-1_5","volume":"1185","author":"G Schnabolk","year":"2019","unstructured":"Schnabolk, G. Systemic inflammatory disease and AMD comorbidity. Adv. Exp. Med. Biol. 1185, 27\u201331 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"31051_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/joim.12227","volume":"276","author":"CM Cheung","year":"2014","unstructured":"Cheung, C. M. & Wong, T. Y. Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment. J. Intern. Med. 276 (2), 140\u2013153 (2014).","journal-title":"J. Intern. Med."},{"key":"31051_CR34","unstructured":"Bill, A., Tornquist, P. & Alm, A. Permeability of the intraocular blood vessels. Trans. Ophthalmol. Soc. U K  100(3), 332\u2013336 (1980)."},{"key":"31051_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","volume":"54","author":"NG Lambert","year":"2016","unstructured":"Lambert, N. G. et al. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res. 54, 64\u2013102 (2016).","journal-title":"Prog Retin Eye Res."},{"issue":"1","key":"31051_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/imr.13130","volume":"313","author":"MK Pangburn","year":"2023","unstructured":"Pangburn, M. K. Initiation of the alternative pathway of complement and the history of tickover. Immunol. Rev. 313 (1), 64\u201370 (2023).","journal-title":"Immunol. Rev."},{"issue":"1","key":"31051_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/imr.13165","volume":"313","author":"K Peters","year":"2023","unstructured":"Peters, K. Physiology and pathology of the C3 amplification cycle: A retrospective. Immunol. Rev. 313 (1), 217\u2013224 (2023).","journal-title":"Immunol. Rev."},{"issue":"2","key":"31051_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jamaophthalmol.2023.5584","volume":"142","author":"IH Schachar","year":"2024","unstructured":"Schachar, I. H. Concerning syfovre approval for geographic atrophy. JAMA Ophthalmol. 142 (2), 85\u201386 (2024).","journal-title":"JAMA Ophthalmol."},{"key":"31051_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2147\/OPTH.S367089","volume":"17","author":"H Khan","year":"2023","unstructured":"Khan, H. et al. Emerging treatment options for geographic atrophy (GA) secondary to age-related macular degeneration. Clin. Ophthalmol. 17, 321\u2013327 (2023).","journal-title":"Clin. Ophthalmol."},{"issue":"3","key":"31051_CR40","first-page":"484","volume":"73","author":"TE Mollnes","year":"1988","unstructured":"Mollnes, T. E., Garred, P. & Bergseth, G. Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation. Clin. Exp. Immunol. 73 (3), 484\u2013488 (1988).","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"31051_CR41","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1309\/AJCPXPD7ZQXNTIAL","volume":"143","author":"S Yang","year":"2015","unstructured":"Yang, S., McGookey, M., Wang, Y., Cataland, S. R. & Wu, H. M. Effect of blood sampling, processing, and storage on the measurement of complement activation biomarkers. Am. J. Clin. Pathol. 143 (4), 558\u2013565 (2015).","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"31051_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/s13104-017-2885-1","volume":"10","author":"AR Morgan","year":"2017","unstructured":"Morgan, A. R., O\u2019Hagan, C., Touchard, S., Lovestone, S. & Morgan, B. P. Effects of freezer storage time on levels of complement biomarkers. BMC Res. Notes. 10 (1), 559 (2017).","journal-title":"BMC Res. Notes"},{"issue":"12","key":"31051_CR43","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","volume":"125","author":"TD Keenan","year":"2018","unstructured":"Keenan, T. D. et al. Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16. Ophthalmology 125 (12), 1913\u20131928 (2018).","journal-title":"Ophthalmology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31051-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31051-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31051-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T18:04:42Z","timestamp":1768327482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31051-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31051"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31051-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"de Carlo Forest: Genentech (advisory board). Manoharan: Iveric Bio (financial support for research), Genentech (consulting). Mandava: Soma Logic (consulting, research), ONL Therapeutics (consulting), Alcon (patent), 2C Holers: Q32 Bio (consulting, equity),Tech (patent, equity, co-founder). Apellis Pharmaceuticals, Chemocentryx (stock), InflaRx (stock), Iveric Bio (stock), Omeros (stock), Invizius (consulting), Alnylam Pharmaceuticals (consulting). No other financial disclosures exist for the remaining authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1442"}}